C5 and hyperinsulinemic hypoglycemia, familial, 4: A strongly diminished response to LPS or whole bacteria was seen in blood from an individual with congenital C5 deficiency, a defect that was phenocopied in normal blood by addition of eculizumab or a C5aR1 antagonist, implicating signaling by soluble C5a rather than MAC deposition in this scenario (145, 146).